Sponsor:
University of Maryland, Baltimore
Code:
NCT05344274
Conditions
Glaucoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Indocyanine Green Angiography
Isocapnic Oxygen
Ocular Imaging with Optical Coherence Tomography (OCT) and Adaptive Optics (AO)
Brief summary:
Conditions
Glaucoma
Study ID
NCT05344274
Start date
May 23, 2022
Status verified date
Nov, 2025
Completion date
Sep, 2027
Anticipated
Primary completion date
Sep, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
90 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: Isocapnic Oxygen
Interventions
Indocyanine Green Angiography
Isocapnic Oxygen
Ocular Imaging with Optical Coherence Tomography (OCT) and Adaptive Optics (AO)
Primary outcome measure
Central contacts
Locations
University of Maryland Faculty Physicians, Inc
Recruiting
Baltimore, Maryland, United States, 21201
University of Maryland Medical Center
Recruiting
Baltimore, Maryland, United States, 21201
University of Maryland, Baltimore
Recruiting
Baltimore, Maryland, United States, 21201
Food and Drug Administration (FDA)
Recruiting
Silver Spring, Maryland, United States, 20903
Sponsor
University of Maryland, Baltimore
Last update posted
Dec 2, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Maryland, Baltimore on 2025-12-02.